Kim HS - Search Results

1

Unveiling the Molecular Landscape of FOXA1 Mutant Prostate Cancer: Insights and Prospects for Targeted Therapeutic Strategies.

Hwang KW, Yun JW, Kim HS. Hwang KW, et al. Among authors: kim hs. Int J Mol Sci. 2023 Oct 31;24(21):15823. doi: 10.3390/ijms242115823. Int J Mol Sci. 2023. PMID: 37958805 Free PMC article.

2

Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer.

Yun JW, Lee S, Chun S, Lee KW, Kim J, Kim HS. Yun JW, et al. Among authors: kim j, kim hs. Clin Transl Med. 2021 May;11(5):e420. doi: 10.1002/ctm2.420. Clin Transl Med. 2021. PMID: 34047472 Free PMC article. No abstract available.

3

Portrait of Molecular Signaling and Putative Therapeutic Targets in Prostate Cancer with ETV4 Fusion.

Shin YJ, Yun JW, Kim HS. Shin YJ, et al. Among authors: kim hs. Biomedicines. 2022 Oct 20;10(10):2650. doi: 10.3390/biomedicines10102650. Biomedicines. 2022. PMID: 36289913 Free PMC article.

4

Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer.

Kim J, Hwang KW, Lee HJ, Kim HS. Kim J, et al. Among authors: kim hs. J Pers Med. 2022 Nov 2;12(11):1818. doi: 10.3390/jpm12111818. J Pers Med. 2022. PMID: 36579559 Free PMC article.

5

Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment.

Lee JH, Kim J, Kim HS, Kang YJ. Lee JH, et al. Among authors: kim j, kim hs. Int J Mol Sci. 2023 Nov 14;24(22):16307. doi: 10.3390/ijms242216307. Int J Mol Sci. 2023. PMID: 38003505 Free PMC article.

6

MED28 Over-Expression Shortens the Cell Cycle and Induces Genomic Instability.

Cho JG, Choi JS, Lee JH, Cho MG, Kim HS, Noh HD, Lim KH, Park B, Kim JO, Park SG. Cho JG, et al. Among authors: kim jo, kim hs. Int J Mol Sci. 2019 Apr 9;20(7):1746. doi: 10.3390/ijms20071746. Int J Mol Sci. 2019. PMID: 30970566 Free PMC article.

7

AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma.

Fan D, Yang M, Lee HJ, Lee JH, Kim HS. Fan D, et al. Among authors: kim hs. Front Mol Biosci. 2023 Oct 16;10:1265359. doi: 10.3389/fmolb.2023.1265359. eCollection 2023. Front Mol Biosci. 2023. PMID: 37908231 Free PMC article.

8

Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.

Lee J, Kim HS, Lee B, Kim HK, Sun JM, Ahn JS, Ahn MJ, Park K, Lee SH. Lee J, et al. Among authors: kim hk, kim hs. Cancer. 2020 Jun 1;126(11):2704-2712. doi: 10.1002/cncr.32809. Epub 2020 Mar 10. Cancer. 2020. PMID: 32154925 Free article.

9

LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.

Kim JE, Kim HS, Shin YJ, Lee CS, Won C, Lee SA, Lee JW, Kim Y, Kang JS, Ye SK, Chung MH. Kim JE, et al. Among authors: kim hs, kim y. Exp Mol Med. 2008 Oct 31;40(5):514-22. doi: 10.3858/emm.2008.40.5.514. Exp Mol Med. 2008. PMID: 18985009 Free PMC article.

10

Anti-inflammatory effects of 8-hydroxydeoxyguanosine in LPS-induced microglia activation: suppression of STAT3-mediated intercellular adhesion molecule-1 expression.

Kim DH, Cho IH, Kim HS, Jung JE, Kim JE, Lee KH, Park T, Yang YM, Seong SY, Ye SK, Chung MH. Kim DH, et al. Among authors: kim hs, kim je. Exp Mol Med. 2006 Aug 31;38(4):417-27. doi: 10.1038/emm.2006.49. Exp Mol Med. 2006. PMID: 16953121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,192 results

Search Page

Filters